GLP-1 and the renin-angiotensin-aldosterone system

Lancet Diabetes Endocrinol. 2019 May;7(5):337. doi: 10.1016/S2213-8587(19)30065-8. Epub 2019 Mar 7.

Authors

David León Jiménez¹, Miguel Camafort Babkowski², José Pablo Miramontes González³

Affiliations

¹ Vascular Risk Unit, Internal Medicine Department, Virgen Rocio University Hospital, Sevilla 41013, Spain. Electronic address: davidleonj@yahoo.es.
² Internal Medicine Department, School of Medicine, University of Barcelona, Barcelona, Spain.
³ Internal Medicine Department, Clinic University Hospital, Valladolid, IBSAL: Instituto de investigaciones biomédicas de Salamanca, Spain.

PMID: 30853620
DOI: 10.1016/S2213-8587(19)30065-8

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiotensin-Converting Enzyme Inhibitors
Diabetes Mellitus, Type 2*
Glucagon-Like Peptide 1
Humans
Renin
Renin-Angiotensin System*

Substances

Angiotensin-Converting Enzyme Inhibitors
Glucagon-Like Peptide 1
Renin